Literature DB >> 12796170

Severe gastroesophageal reflux is associated with reduced carbon monoxide diffusing capacity.

Linda M Schachter1, John Dixon, Robert J Pierce, Paul O'Brien.   

Abstract

OBJECTIVE: To assess whether severe gastroesophageal reflux (GER) is associated with abnormalities in lung function including measures of lung volume and gas diffusion.
METHODS: Data from 147 patients with obesity (body mass index [BMI] range, 31.7 to 70 kg/m(2)) who presented for obesity surgery was analyzed retrospectively. A questionnaire was completed preoperatively that included a history of GER, frequency and severity of symptoms, investigations, and medications used. A history of lung disease, sleep-disordered breathing, and smoking also was obtained. A physician who was blinded to lung function graded GER severity prospectively by the results of pH monitoring and/or gastroscopy, and medication use. Spirometry, lung volumes, and gas transfer were measured preoperatively.
RESULTS: Patients with severe GER had reduced levels of the diffusing capacity of the lung for carbon monoxide (DLCO) [21.1 mL/min/mm Hg; 95% confidence interval (CI), 18.9 to 23.2], as measured by CO transfer, compared with those patients without GER (26.3 mL/min/mm Hg; 95% CI, 24.4 to 28.2; p = 0.001). This remained significant after adjusting for age, gender, BMI, and smoking history. Gas transfer corrected for lung volume also was reduced in the group with severe GER (4.6 mL/min/mm Hg per L; 95% CI, 4.3 to 4.9) compared to the group without GER (5.3 mL/min/mm Hg per L; 95% CI, 5.1 to 5.5; p = 0.001). There was no significant difference in other measures of lung function.
CONCLUSIONS: Severe GER is associated with an impairment of gas exchange. This may be due to microaspiration of gastric acid or fluid into the airways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796170     DOI: 10.1378/chest.123.6.1932

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Systemic Sclerosis and Pulmonary Disease.

Authors:  Khoa Ngo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  New perspectives on management of idiopathic pulmonary fibrosis.

Authors:  Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Riccardo Giuliano; Stefano Palmucci; Massimiliano Mulè; Carlo Vancheri
Journal:  Ther Adv Chronic Dis       Date:  2016-02-01       Impact factor: 5.091

3.  Gastroesophageal reflux disease and pulmonary function: a potential role of the dead space extension.

Authors:  Damir Bonacin; Damir Fabijanić; Mislav Radić; Željko Puljiz; Gorana Trgo; Andre Bratanić; Izet Hozo; Jadranka Tocilj
Journal:  Med Sci Monit       Date:  2012-05

4.  Gastroesophageal reflux disease in our asthma patients: the presence of dysphagia can influence pulmonary function.

Authors:  Gulfidan Aras; Dilek Kanmaz; Figen Kadakal; Sevim Purisa; Kenan Sonmez; Esin Tuncay; Arzu Ozdemir
Journal:  Multidiscip Respir Med       Date:  2012-12-17

5.  Bronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control study.

Authors:  Emilija Lozo Vukovac; Mislav Lozo; Kornelija Mise; Ivan Gudelj; Željko Puljiz; Anamarija Jurcev-Savicevic; Anteo Bradaric; Josipa Kokeza; Josko Mise
Journal:  Med Sci Monit       Date:  2014-02-15

6.  Lung diffusion capacity in children with respiratory symptoms and untreated GERD.

Authors:  Mirjana Mirić; Mirjana Turkalj; Boro Nogalo; Damir Erceg; Marija Perica; Davor Plavec
Journal:  Med Sci Monit       Date:  2014-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.